1. Korzeniewski, S.J., Grigorescu, V., Copeland, G., Gu, G., Thoburn, K.K., Rogers, J.D., & Young, W.I. (2009). Methodological innovations in data gathering: Newborn screening linkage with live births records, Michigan, 1/2007-3/2008. Maternal and Child Health Journal, Retrieved April 8. 2009, from http://www.ncbi.nlm.nih.gov/pubmed/19353254.
   
   
2. Xu, X., Grigorescu, V., Siefert, K.A., Lori, J.R., & Ransom, S.B.  (2009). Cost of racial disparity in preterm birth: Evidence from Michigan. Journal of Health Care for the Poor and Underserved, 20, 729-747
   
   
3. Jennifer Couzin-Frankel (2009)   Newborn Blood Collections: Science Gold Mine, Ethical Minefield. Science 10 April 2009:Vol. 324. no. 5924, pp. 166 - 168
   
   
4. Sørensen, K.M., Agergaard, P., Olesen, C., Andersen, P.S., Larsen, L.A., Østergaard, J.R., Schouten, J.P., & Christiansen, M. (2010). Detecting 22q11.2 Deletions by Use of Multiplex Ligation-Dependent Probe Amplification on DNA from Neonatal Dried Blood Spot Samples. Journal of Molecular Diagnostics, Vol. 12, No. 2, March 2010, doi:10.2353/jmoldx.2010.090099
   
   
5. Yanni, E.A., Copeland, G., & Olney, R.S. (2008). Birth defects and genetic disorders among Arab Americans-Michigan, 1992-2003. Journal of Immigrant and Minority Health, Retrieved April 8, 2009, from http://www.ncbi.nlm.nih.gov/pubmed/18972209.
   
   
6. Bradley, C.J., Given, C.W., Luo, Z., Roberts, C., Copeland, G., & Virnig, B.A. (2007). Medicaid, Medicare, and the Michigan Tumor Registry: a linkage strategy. Medical Decision Making, 27, 352-363.
   
   
7. Simon, M.S., Mueller, B.A., Deapen, D., & Copeland, G. (2005). A comparison of record linkage yield for health research using different variable sets. Breast Cancer Research and Treatment, 89, 107-110.
   
   
8. Grigorescu, V., Paustian, M., Copeland, G., El Reda, D., & Baker, G. (2005). Contribution of preterm to Michigan’s children's special health care services program population. Journal of Registry Management, 32, 132-136.
   
   
9. Klotz, J., Bryant, P., Wilcox , H.B., Dillon, M., Wolf, B., & Fagliano , J. (2006). Population-based retrieval of newborn dried blood spots for researching paediatric cancer susceptibility genes. Paediatric and Perinatal Epidemiology, 20, 449-452.
   
   
10. Olney, R., Moore, C., Ojodu , J., Lindegren, M., & Hannon, W. (2006). Storage and use of residual dried blood spots from state newborn screening programs. The Journal of Pediatrics, 148, 618-622.
    
    
11. Henderson, L.O., Powell, M.K., Hannon, W.H., Bernert, J.T., Pass, K.A., Fernhoff , P., Ferrell, C.D., Martin, L., Franko, E., Rochat, R.W., Brantley, M.D., & Sampson, E. (1997). An evaluation of the use of dried-blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. Biochemical and Molecular Medicine, 61, 143-151.
    
    
12. Burse , V.W. , DeGuzman, M.R., Korver, M.P., Najam, A.R., Williams, C.C., Hannon, W.H., & Therrell B.L. (1997). Preliminary investigation of the use of dried blood spots for the assessment of in utero exposure to environmental pollutants. Biochemical and Molecular Medicine, 61, 236-239.
    
    
13. Haak, P.T., Busik, J.V., Kort, E.J., Tikhonenko, M., Paneth, N., & Resau, J.H. (2009). Archived unfrozen neonatal blood spots are amenable to quantitative gene expression analysis. Neonatology, 95, 210-216.
    
    
14. Goldenberg, A.J., Chandros Hull, S., Botkin, J.R., & Wilfond, B.S. (2009). Pediatric Biobanks: Approaching informed consent for continuing research after children grow up. The Journal of Pediatrics, Retrieved July 10, 2009, from http://www.ncbi.nlm.nih.gov/pubmed/19595370.
    
    
15. Hollegaard, M.V., Grauholm , J., Børglum, A., Nyegaard, M., Nørgaard-Pedersen , B., Ørntoft, T., Mortensen, P.B., Wiuf , C., Mors, O., Didriksen, M., Thorsen, P., & Hougaard, D.M. (2009). Genome –wide scans using archived neonatal dried blood spot samples. BMC Genomics, 10, Retrieved July 10, 2009, from http://www.ncbi.nlm.nih.gov/pubmed/19575812
    
    
16. Hardin, J., Finnell, R.H., Wong, D., Hogan, M.E., Horovitz, J., Shu, J., & Shaw, G.M. (2009). Whole genome microarray analysis, from neonatal blood cards   BMC Genetics, Retrieved July 10, 2009, from http://www.ncbi.nlm.nih.gov/pubmed/19624846.
    
    
17. Oglesbee, D., Sanders, K.A., Lacey, J.M., Magera, M.J., Casetta, B., Strauss, K.A., Tortorelli, S., Rinaldo, P., & Matern, D. (2008). Second tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). Clinical Chemistry, Retrieved July 10, 2009, from http://www.ncbi.nlm.nih.gov/pubmed/18178665.
    
    
18. Coleman, T., Magera, M.J., Allard, P., Tortorelli, S., Gavrllov, D., Oglesbee, D., Kimlyo, R., Rinaldo, P., & Matern, D. (2008). Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clinical Chemistry, Retrieved July 10, 2009, from http://www.ncbi.nlm.nih.gov/pubmed/18281422.
    
    
19. Strnadova, K.A., Holub, M., Muhl, A., Heinze, G., Ratschmann, R., Mascher, H., Stockler-Ipsiroglu, S., Waldhauser, F., Votava, F., Lebl, J., & Bodamer, O.A. (2007). Long-term stability of amino acids and acylcarnitines in dried blood spots. Clinical Chemistry, 53, 717-722.
    
    
20. Leruez-Ville, Marianne, Vauloup-Fellous, Christelle, Couderc, Sophie, Parat, Sophie, Oucherif, Sallima, Magny,Jean-Francois. (2009) New approach for congenital CMV infection diagnosis in neonates: sensibility and specificity of CMV detection in dried blood spots. This article is part of the supplement Fifth Dominique Dormont International Conference. Host-Pathogen Interactions in Chronic Infections. Retrovirology, Retrieved September 4, 2009 from http://www.retrovirology.com/content/6/S1/O12